Results

Total Results: 1,210 records

Showing results for "death".

81. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/questions-what-are-the-appropriate-indications-for-tonsillectomy-recurrent-infections-how-many-sleep-disordered-breathingshould-clinicians-administer-or-prescribe-perioperative-antibiotics-to-children-undergoing-tonsillectomy
    August 20, 2014 - current estimates of tonsillectomy mortality but a prospective audit reported only 1 postoperative death … electrolyte imbalance or anesthetic complications.1626 Similarly airway compromise is the major cause of death

82. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research
    November 04, 2013 - Compared with clopidogrel, prasugrel reduced rates of cardiovascular death, myocardial infarction, or … PPI) use (any type with dual antiplatelet use) and increased rates of composite ischemic endpoints, death

83. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - Where this is not possible (e.g., cause of death), the logic requires an asserted relationship. … Spondylolisthesis Outcome Measures OMF CATEGORY OUTCOME MEASURE DEFINITION Survival All-cause death … at 30 days All-cause death within 30 days of treatment. … Collect cause of death when possible.

84. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
    March 01, 2021 - Where this is not possible (e.g., cause of death), the logic requires an asserted relationship. … Spondylolisthesis Outcome Measures OMF CATEGORY OUTCOME MEASURE DEFINITION Survival All-cause death … at 30 days All-cause death within 30 days of treatment. … Collect cause of death when possible.

85. Localized Prostate Cancer | Effective Health Care
    effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/08.html
    June 08, 2018 - age and health status, these men will likely not die of prostate cancer but of other common causes of death

86. Ch 9-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ch_9-user-guide-to-ocer_130129.pdf
    September 21, 2012 - deviation of the outcome in each trial arm; when the outcome is the occurrence of an event (e.g., death … Example study size table for an RCT comparing the risk of death for two alternative therapies* Scenario … Risk of death associated with use of conventional versus atypical antipsychotic drugs among elderly … Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

87. Back (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/back.pdf
    January 01, 2011 - patients and  families wrestling with complex medical   decisions, finding a way to  approach  death … www.effectivehealthcare.ahrq.gov/index.cfm) � o Therapy to prepare for death

88. Anticoagulation for Venous Thromboembolic Events in Patients with Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-venous-thrombosis-anticoagulation/abstract
    December 15, 2009 - , investigators will compare the effectiveness of each anticoagulant treatment at preventing VTE or death

89. Localized Prostate Cancer | Effective Health Care
    effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/04.html
    June 08, 2018 - Prostate cancer is the second most common type of cancer to cause death in American men (lung cancer

90. Jensen_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/jensen_eccs2012.pdf
    January 01, 2012 - to manage patient communication Slide 9: Future Research Questions  and Courses  of Action • Death

91. Cad-Pci-Bypass Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
    May 01, 2013 - Rates of death and myocardial infarction were not statistically different between groups. … disease were randomized to CABG or PCI with drug-eluting stents 1900 The composite outcome of death … randomized to CABG or PCI, initially bare metal stents but later drug-eluting stents 510 The rate of death … artery disease were randomized to CABG or PCI with drug-eluting stents 600 The composite rate of death … artery disease were randomized to CABG or PCI with drug eluting stents 201 The combined rate of death

92. Enzyme Replacement Therapy for Lysosomal Storage Disorders | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/research-protocol
    October 05, 2011 - Life expectancy is < 10 years, with cause of death most commonly due to obstructive airway disease, upper … Life expectancy ranges from 10-20 yrs, with cause of death usually due to heart disease, from valvular … expectancy depends on severity of symptoms, ranging from <20 yrs to later adulthood, with cause of death … Life expectancy is 40 - 50 yrs, with cause of death usually due to a decline in kidney function or to … Life expectancy is variable, depending on severity and rate of disease progression, with cause of death

93. Terbutaline Pump for the Prevention of Preterm Birth | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/preterm-birth-terbutaline-pump/research
    September 29, 2011 - twin gestation, the strength of evidence favoring the pump over oral tocolytics is low for neonatal death

94. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/late-long-term-effects-aya-cancer
    May 03, 2021 - diagnosed with cancer in the United States, which makes cancer the leading cause of disease-related death

95. Cer-242-Radiation-Therapy-Brain-Metastases-Evidence-Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
    June 01, 2021 - of brain metastases may have substantial prognostic implications by causing neurologic symptoms or death

96. Cystic-Fibrosis-Hgh Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - Hyperglycemia and death in cystic fibrosis- related diabetes. … (adjusted HR 4.05, 1.15, 14.28, p=0.03) or 3-year risk of death (unadj. … Death was associated with body mass index <19 (adjusted HR1.52, 95% CI 1.10, 2.10, p=0.011); use … Participation in registry Retrospective cohort study Risk factors associated with death in CF … Most common cause of death was CNS tumor (recurrence or new onset). 11% of deaths were judged

97. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix F2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - NR NR NR NR NR NR NR NR Clegg, 2006 Good OA (knee) NSAID Celecoxib 200 mg/d 24 Short 7 318 NR NR CV death … NR NR NR NR NR NR NR NR NR NR Clegg, 2006 Good OA (knee) Placebo Placebo 24 Short 11 313 NR NR CV death … NR NR NR NR NR NR Silverstein, 2000 Good Mixed Diclofenac 150 mg/d 26 Intermediate NR NR NR NR CV death … NR NR NR NR NR NR Silverstein, 2000 Good Mixed Ibuprofen 2400 mg/d 26 Intermediate NR NR NR NR CV death … NR NR NR Nissen, 2016 Fair Mixed Celecoxib 200 to 400 mg/d (mean 209 mg/d) 80 Long NR NR NR NR CV death

98. Partnering with Patients to Disseminate Research Products (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/sadwin.pdf
    January 01, 2011 - Partnering with Patients to Disseminate Research Products …

99. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/renal-mass-and-localized-renal-cancer-the-following-questions-are-recommended-to-address-the-healthcare-tests-andor-treatments-this-program-should-consider-what-indicators-can-be-used-to-predict-malignancy-andor-aggressivenes
    October 24, 2013 - What is the role of competing risks of death, related to age and medical-co-morbidities, in managing … Approximately 30% of tumors recur and 20% of adult instances of renal cancer result in death. … blood transfusion Respiratory complications Cardiovascular complications Venous thromboembolism Death

100. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/copd-management/research
     December 04, 2009 - ipratropium plus theophylline, compared to ipratropium alone, had a 1.11-fold increase in the risk of death